10,000 Shares in Nexalin Technology, Inc. (NASDAQ:NXL) Bought by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC bought a new stake in Nexalin Technology, Inc. (NASDAQ:NXL) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 10,000 shares of the company’s stock, valued at approximately $28,000. Kingsview Wealth Management LLC owned about 0.08% of Nexalin Technology at the end of the most recent quarter.

Separately, Drive Wealth Management LLC acquired a new stake in shares of Nexalin Technology during the fourth quarter worth $55,000. 0.65% of the stock is currently owned by institutional investors.

Nexalin Technology Stock Performance

Nexalin Technology stock opened at $3.31 on Friday. The stock has a market cap of $44.02 million, a PE ratio of -5.17 and a beta of 4.20. Nexalin Technology, Inc. has a fifty-two week low of $0.29 and a fifty-two week high of $4.49. The firm’s 50-day simple moving average is $3.12 and its 200 day simple moving average is $2.26.

Analyst Upgrades and Downgrades

Separately, Maxim Group reaffirmed a “hold” rating on shares of Nexalin Technology in a research report on Thursday, December 5th.

About Nexalin Technology

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia.